Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-219-6 | CAS number: 68037-95-6 This substance is identified by SDA Substance Name: C16-C18 and C18 unsaturated alkyl amine and SDA Reporting Number: 11-029-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to acceptable standards including GLP
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Principles of method if other than guideline:
- Study was performed before actual guideline was adopted (21 Jul 1997).
- GLP compliance:
- yes
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- (Z)-octadec-9-enylamine
- EC Number:
- 204-015-5
- EC Name:
- (Z)-octadec-9-enylamine
- Cas Number:
- 112-90-3
- Molecular formula:
- CH3(CH2)7CH=CH(CH2)7CH2NH2
- IUPAC Name:
- octadec-9-en-1-amine
- Reference substance name:
- (Z)-octadec-9-en-1-amine
- IUPAC Name:
- (Z)-octadec-9-en-1-amine
- Reference substance name:
- Oleyl Alkylamines
- IUPAC Name:
- Oleyl Alkylamines
- Details on test material:
- - Name of test material (as cited in study report): Oleylamine
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague Dawley, Inc., Frederick , MD, USA
- Age at study initiation: 6-8 weeks old
- Weight at study initiation: males: 28-38 g; females: 22-28 g
- Assigned to test groups randomly: The animals were assigned to 13 experimental groups of 5 males and 5 females each based on a computer-generated random number table.
- Housing: The animals were housed in plastic autoclavable cages with filter tops during quarantine and the experimental period. Hardwood chips were used for bedding.
- Diet (e.g. ad libitum): certified laboratory rodent chow which had been analysed for environmental contaminants; ad libitum
- Water (e.g. ad libitum): tap water; ad libitium
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-25 °C
- Humidity (%): 50±20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Amount of vehicle (if gavage or dermal): 10 mL/kg bw
- Lot/batch no. (if required): Sept1389J (Giant Foods, Washington, D.C., USA) - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test article was dissolved in a total volume of 10 mL/kg bw. - Duration of treatment / exposure:
- single administration
- Frequency of treatment:
- single administration
- Post exposure period:
- 6, 12, or 24 h
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 2500, 5000 mg/kg
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine: dissolved in sterile distilled water at a concentration of 0.05 mg/mL
- Route of administration: injection
Examinations
- Tissues and cell types examined:
- bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Based on the preliminary dose-finding study, the doses for the main study were selected.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Colchicine, used to arrest dividing cells at metaphase, was administered ip at 1 mg/kg to all mice two to four hours prior to sacrifice. Animals were sacrificed by carbon dioxide asphyxiation. Immediately following sacrifice, the femur was exposed and the bone marrow was aspirated.
DETAILS OF SLIDE PREPARATION:
The cells were centrifuged and resuspended in a fixative (methanol:acetic acid, 3:1, v/v). The cell suspension was dropped onto a wet glass slide and dried. 3 slides were prepared from each animal. The dry slides were stained with 5% Giemsa stain.
METHOD OF ANALYSIS:
A minimum of 50 metaphase cells containing 40±2 centromeres were examined from each animals and scored for chromatid-type and chromosome-type aberrations. Chromatid and isochromatid gaps were recorded but not included in the analysis. The mitotic index was recorded as the percentage number of cells in mitosis based upon 500 cells counted per animals. - Evaluation criteria:
- The test article was considered to induce a positive response when the number of aberrant cells was significantly increased in a dose responsive manner relative to the vehicle control. A significant increase at the high dose only with no dose-response was considered suspect.
The percentage of cells in the solvent control group demonstrating aberrations of any type, other than gaps, must not exceed 4%. The cells with aberrations in the positive control group must be statistically increased (p≤0.05, Fisher´s Exact Test). - Statistics:
- Fisher´s Exact Test; Cochran-Armitage trend test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- One female receiving 2500 mg/kg died prior to colchicine administration.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 763, 1221, 1953, 3125, 5000 mg in corn oil/kg bw
- Clinical signs of toxicity in test animals: diarrhea, ruffled fur, crusty eyes and hunched posture (one female receiving 5000 mg/kg, one female receiving 3125 mg/kg, one female receiving 1221 mg/kg were found dead)
- Other: A single administration of 5000 mg/kg was selected as the high dose for the cytogenetics study.
RESULTS OF DEFINITIVE STUDY
- The marginal increases in percentage of aberrant cells observed in the high dose group were not statistically significant (p>0.05, Fisher´s exact test). In fact, the percentage of damaged cells was not significantly increased in the Oleylamine-treated animals, regardless of sex, dose or sacrifice time (p>0.05, Fisher´s exact test).
One female receiving 2500 mg/kg died prior to colchicine administration. No significant reduction in the rate of body weight gain was observed. Clinical observations in treated animals included diarrhea, piloerection, lethargy, crusty eyes and irregular breathings.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under the conditions of the assay, Oleylamine at dose levels of 500, 2500 and 5000 mg/kg body weight was negative in the in vivo cytogenetic assay using male and female ICR mice. The negative and positive controls fulfilled the requirements for determination of a valid test. - Executive summary:
A chromosomal aberration test in mice bone marrow cells with octadecenylamine ("Oleylamine") was performed. Groups of five male and five female mice were administered single doses of 500, 2500 or 5000 mg/kg bw in corn oil by oral gavage at a volume of 10 ml/kg bw (purity >90%). Bone marrow cells were collected 6, 12 and 24 hours after treatment. No increases in percentages of aberrant cells were observed in the test substance treated animals regardless of dose or harvest time. One female in the 2500 mg/kg bw group died prematurely. No significant reduction in the rate of body weight gain was observed. Clinical signs of toxicity were observed in test substance-treated mice indicating that the test substance was systemically available after oral application. Based on the test results, oleylamine was negative in this in vivo mutagenicity assay. The concurrent negative and positive controls fullfilled the requirements for a valid test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.